Visicell Announces Closing of Convertible Note Financing
Visicell Medical Inc. had successfully closed the oversubscribed $1 million dollars convertible note offering led by industry expert Life...
top of page
Vision, Empowered
TM
Our Recent Posts
Archive
Tags
No tags yet.
Dr. Mark Stolowitz joins Visicell as Chief Science Officer
Visicell is proud to announce the newest addition to our stellar executive team. After retiring in May of 2019 from the Canary Center at...
Visicell is now a StartX company
After completing a highly competitive and selective admission process, Visicell and its co-founders had been invited to join the...
VisiCELL is presenting at 2020 Cell and Gene Meeting on the Mesa
Visicell is presenting at Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa! Taking place October 12-16, this virtual...
A record year for biopharma M&A in 2019
We saw lots of action in the biopharma merger and acquisition (M&A) space in 2019, headlined by Bristol-Myers Squibb acquiring Celgene...
Kicking off the Visicell Advisory Board with a bang!
We proudly introduce the newest addition to the Visicell family, the Visicell Board of Advisors: George Smith, PhD, MBA Director, Cell &...
bottom of page